Skip to main content
OpenTrials
Completed

NCT Number: NCT00292409

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

The purpose of this clinical research study is to evaluate the overall effectiveness of 8 week of aripiprazole treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia and Schizoaffective Disorder Mental Disorders Psychotic Disorders Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of schizophrenia or schizoaffective disorder being treated as outpatients,no response to past antipsychotic treatment and patients who symptoms are notoptimally controlled defined as CGI- S<7

Exclusion criteria

  • pregnant or breastfeeding,patients at risk for committing suicide,diagnosis of mood disorders, delirium, dementia and other cognitive disorders,patients treatment resistant to otherantipyschotic medications and treatment with a long acting psychotic in which the last dose was within 3 months of treatment phase

Treatment and study plan

Aripiprazole

Drug

Primary outcomes

  1. Clinical Global Impression-Improvement at endpoint

Secondary outcomes

  1. Clinical Global Impression scale

  2. Investigator's Assessment Questionnaire

  3. Patient preference of medication at endpoint

Sponsors and collaborators

Lead sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Industry

Collaborators

  • Otsuka America Pharmaceutical

Registry information

Official study title

A Prospective Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Feb 16, 2006
Registry last updated
Nov 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.